Tequin: Another Antibiotic Found to be Killing People
March 18, 2006
The antibiotic Tequin, manufactured by Bristol-Myers Squibb, can cause potentially fatal swings in blood sugar.
Greater Risk Than Previously Thought
A new study shows that the drug's risks are far greater than they were believed to be. The FDA has already warned doctors not to prescribe the antibiotic to diabetic patients. However, the blood sugar swings have now been observed even in patients without diabetes.
17 Times the Risk
An examination of the medical records of almost 1.5 million people older than 65 showed that those who took Tequin had four times the risk of low blood sugar, and almost 17 times the risk of high blood sugar.
Those who took Tequin were also far more likely to be hospitalized for blood sugar problems, and a number of such patients died.
Tequin made $150 million in worldwide sales last year. It is used to treat lung, sinus and urinary tract infections, and also some sexually transmitted diseases. Alternative antibiotics are available for all of its uses.